AI ETI LLC - 12 Aug 2021 Form 4 Insider Report for Eliem Therapeutics, Inc. (CLYM)

Role
10%+ Owner
Signature
/s/ Alejandro Moreno for AI ETI LLC
Issuer symbol
CLYM
Transactions as of
12 Aug 2021
Net transactions value
+$10,000,000
Form type
4
Filing time
16 Aug 2021, 16:21:39 UTC
Previous filing
09 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELYM Common Stock Conversion of derivative security $0 +4,209,400 $0.000000 4,209,400 12 Aug 2021 Direct F1, F2
transaction ELYM Common Stock Purchase $10,000,000 +800,000 +19% $12.50 5,009,400 12 Aug 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Series A Redeemable Convertible Preferred Stock Conversion of derivative security $0 -3,568,375 -100% $0.000000* 0 12 Aug 2021 Common Stock 3,568,375 Direct F1, F2
transaction ELYM Series B Redeemable Convertible Preferred Stock Conversion of derivative security $0 -641,025 -100% $0.000000* 0 12 Aug 2021 Common Stock 641,025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Redeemable Convertible Preferred Stock and Series B Redeemable Convertible Preferred Stock was automatically converted into one share of common stock upon the completion of Eliem Therapeutics, Inc.'s (the "Issuer") initial public offering and had no expiration date.
F2 The securities reported are held directly by AI ETI LLC and may be deemed to be beneficially owned by Access Industries Holdings LLC ("AIH"), Access Industries Management, LLC ("AIM") and Len Blavatnik because AIH indirectly controls all of the outstanding voting interests in AI ETI LLC, AIM controls AIH and Mr. Blavatnik controls AIM and holds a majority of the outstanding voting interests in AIH. AIH, AIM and Mr. Blavatnik each disclaims beneficial ownership of these securities, except to the extent of its or his pecuniary interest therein, and this form shall not be construed as an admission that any such reporting person is the beneficial owner of any of the securities reported on this form.
F3 Represents securities purchased in the Issuer's initial public offering.